No Stock Yet
ZIVOW ZIVO BIOSCIENCE INC C/WTS 14/05/2026 (TO PUR COM)
0.504-0.046-8.36%
YOY
Do not show
(FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30
Financial Ratios
Efficiency Ratios TTM
ROIC
--
-259.419%
--
-259.419%
--
-199.017%
--
-157.997%
ROE
--
-289.983%
--
-289.983%
--
-218.608%
--
-177.870%
ROA
20.90%
-157.386%
20.90%
-157.386%
7.96%
-130.858%
35.10%
-108.425%
Efficiency Ratios
ROA 5 Year Average
14.35%
-2063.951%
--
--
--
--
--
--
Profitability Ratios TTM
Financial Health Ratios
Long-Term Debt to Equity Ratio
--
--
--
--
18,795.41%
8.654%
197.83%
5.215%
Total Assets to Common Equity
--
--
--
--
76.22%
260.546%
28.66%
194.810%
Debt to Asset Ratio
--
--
--
--
1,012.44%
39.647%
342.14%
27.657%
Current Ratio
-69.14%
0.9378
-69.14%
0.9378
-47.75%
1.6105
-31.63%
2.0766
Quick Ratio
-70.61%
0.8873
-70.61%
0.8873
-51.97%
1.4625
-37.04%
1.8848
GrowthRatios
Growth Ratios
Revenue CAGR（3Y）
--
0.000%
--
--
--
--
--
--
Revenue CAGR（5Y）
--
0.000%
--
--
--
--
--
--
Currency Unit
USDUSDUSDUSD
FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.
Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.
The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%
Company Overview
More
CEO： Mr. John B. Payne
Market： NASDAQ
Listing Date： 05/28/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist